Ciltacabtagene autoleucel heralds the arrival of fixed-duration therapies in myeloma2026-07-140 PRE AI GGhulam Rehman Mohyuddin *EEdward R. Scheffer Cliff RRajshekhar Chakraborty DOI:10.1038/s41571-026-01185-4OriginalOriginal request for helpShareSaveAbstract En